KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma

NCT03925870 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: KN046

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd